Epstein‐barr virus specific IgA serum antibodies in nasopharyngeal and other respiratory carcinomas | Zendy

Desgranges C. | Zendy; DeThé G. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Epstein‐barr virus specific IgA serum antibodies in nasopharyngeal and other respiratory carcinomas

Author(s) -

Desgranges C.,

DeThé G.

Publication year - 1979

Publication title -

international journal of cancer

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.475

H-Index - 234

eISSN - 1097-0215

pISSN - 0020-7136

DOI - 10.1002/ijc.2910240506

Subject(s) - nasopharyngeal carcinoma , antibody , virus , immunoglobulin a , epstein–barr virus , carcinoma , medicine , respiratory system , immunology , pathology , immunoglobulin g , radiation therapy

In order to better understand the relationship between IgA and IgG antibodies to Epstein‐Barr virus (EBV) in nasopharyngeal carcinoma (NPC), we analyzed 230 NPC sera but also a series of sera from patients with other carcinomas selected for their high EBV/IgG antibody titres. We were surprised to find that 21 out of 46 sera from bronchopulmonary carcinomas (BPC) and 6 out of 7 carcinomas of nasal fossae were IgA anti‐VCA positive, and 9 BPC sera and 5 nasal fossae sera were also positive for IgA anti‐EA. Bronchial undifferentiated small‐cell carcinomas may represent a particular group associated with high EBV profile.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research